Cargando…

Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis

BACKGROUND: Recent developments related to a safe and effective nonabsorbable antibiotic, rifaximin, and identification of postinfectious irritable bowel syndrome as a frequent sequela call for a need to reconsider the value of primary prevention of traveler’s diarrhea (TD) with antibiotics. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alajbegovic, Sanjin, Sanders, John W, Atherly, Deborah E, Riddle, Mark S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441921/ https://www.ncbi.nlm.nih.gov/pubmed/22929178 http://dx.doi.org/10.1186/2046-4053-1-39

Ejemplares similares

Probiotics and rifaximin for the prevention of travelers’ diarrhea: A systematic review and network meta-analysis
por: Fan, Hao, et al.
Publicado: (2022)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers’ Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD)
por: Gutierrez, Ramiro L, et al.
Publicado: (2020)

Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score
por: Maier, Nicole, et al.
Publicado: (2023)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

A Multisite Network Assessment of the Epidemiology and Etiology of Acquired Diarrhea among U.S. Military and Western Travelers (Global Travelers’ Diarrhea Study): A Principal Role of Norovirus among Travelers with Gastrointestinal Illness
por: Ashbaugh, Hayley R., et al.
Publicado: (2020)

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Rezaie, Ali, et al.
Publicado: (2019)

Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
por: McCusker, Margaret E., et al.
Publicado: (2003)

Rifaximin has the potential to prevent complications of cirrhosis
por: Flamm, Steven L., et al.
Publicado: (2018)

Efficacy and Safety of Rifaximin in the Prevention of Recurrent Episodes of Hepatic Encephalopathy: A Systematic Review and Meta-analysis
por: Elmoursi, Ahmed, et al.
Publicado: (2023)

Rifaximin Is Effective for the Treatment of Clostridium difficile—Associated Diarrhea: Results of an Open-Label Pilot Study
por: Rubin, David T., et al.
Publicado: (2011)

Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review
por: Sidhu, Gurpartap S, et al.
Publicado: (2017)

Cholera in travellers: a systematic review
por: Connor, Bradley A, et al.
Publicado: (2019)

Reduced Fluoroquinolone Susceptibility in Salmonella enterica Isolates from Travelers, Finland
por: Lindgren, Marianne M., et al.
Publicado: (2009)

Military and Civilian Sector Practice Patterns for Short-Term Travelers’ Diarrhea Self-Treatment in Adults
por: Stagliano, David R., et al.
Publicado: (2022)

Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis
por: Fu, Jian, et al.
Publicado: (2022)

Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
por: DuPont, Herbert L., et al.
Publicado: (2016)

Epidemiology and associated microbiota changes in deployed military personnel at high risk of traveler's diarrhea
por: Walters, William A., et al.
Publicado: (2020)

Norovirus: new developments and implications for travelers’ diarrhea
por: Simons, Mark P., et al.
Publicado: (2016)

Fluoroquinolone Resistance in Campylobacter jejuni Isolates in Travelers Returning to Finland: Association of Ciprofloxacin Resistance to Travel Destination
por: Hakanen, Antti, et al.
Publicado: (2003)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
por: Gatta, L., et al.
Publicado: (2017)

Travelers’ Diarrhea: A Clinical Review
por: Leung, Alexander K.C., et al.
Publicado: (2019)

Travelers’ diarrhea: update on the incidence, etiology and risk in military and similar populations – 1990-2005 versus 2005–2015, does a decade make a difference?
por: Olson, Scott, et al.
Publicado: (2019)

Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
por: Yang, Lianjun, et al.
Publicado: (2019)

Case–Case Analysis Using 7 Years of Travelers' Diarrhea Surveillance Data: Preventive and Travel Medicine Applications in Cusco, Peru
por: Jennings, Mary Carol, et al.
Publicado: (2017)

T.D. Lee
por: CERN PhotoLab
Publicado: (1965)

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin
por: Chang, Christopher
Publicado: (2018)

Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2020)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

Rifaximin for Pertuzumab-Related GI Toxicities
por: Soyano, Aixa E., et al.
Publicado: (2017)

Salmonella infection of breast implant associated with traveler's diarrhea: A case report
por: Hall, Bradley R., et al.
Publicado: (2018)

Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
por: Lurchachaiwong, Woradee, et al.
Publicado: (2019)

The Prevalence of Norovirus in returning international travelers with diarrhea
por: Apelt, Nadja, et al.
Publicado: (2010)

439. Impact of Pre-Travel Consultation on Clinical Management and Outcomes of Traveler’s Diarrhea
por: Tan, Eugene M, et al.
Publicado: (2018)

433. Impact of Malaria Prophylaxis on Risk of Travelers’ Diarrhea Among International Travelers
por: Lago, Kathryn, et al.
Publicado: (2018)

Doxycycline Malaria Prophylaxis Impact on Risk of Travelers’ Diarrhea among International Travelers
por: Lago, Kathryn, et al.
Publicado: (2020)

Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler’s diarrhea attack rates among travelers to India: a systematic review and meta-analysis
por: Muzembo, Basilua Andre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5cfh169ojacji769c2uluud2g